Research

Scientists find that close interactions between the mechanical properties of tissues and biochemical signalling between cells drive critical cell fate decisions during zebrafish embryo development Summary Embryonic development is one of the most dynamic biological processes in nature. Cells and tissues organise and reorganise themselves following incredibly precise patterns, while remaining flexible and robust. Scientists […]

Data highlight a mechanistic link between ribosomal stress pathways and biomarker generation, with potential implications for patient stratification and treatment response HEIDELBERG, Germany, June 2, 2026 – Hummingbird Diagnostics GmbH, a molecular diagnostics company focused on blood-based tests for early disease detection and precision medicine, today announced that it will present new findings supporting the […]

Prof. Dr. Rohini Kuner of the Heidelberg Faculty of Medicine at Heidelberg University awarded the 2026 Jung Prize for Medicine Chronic pain is among the most common and burdensome health conditions worldwide. But which processes in the nervous system cause pain to be “learned” and thus persist long term? And how can insights into the […]

Rodríguez-Correa, E., Grünschläger, F., Nizharadze, T. et al. A kinetics-based model of haematopoiesis reveals extrinsic regulation of skewed lineage output from stem cells. Nat Cell Biol (2026). https://doi.org/10.1038/s41556-026-01958-0 https://www.nature.com/articles/s41556-026-01958-0 Abstract Haematopoietic stem cells (HSCs) display extensive molecular and functional heterogeneity. However, a cohesive model that explains the relationship and biological relevance of these diverse HSC states remains elusive. Here, […]

Joint press release of the Heidelberg Faculty of Medicine at Heidelberg University and the German Center for Infection Research: With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the German Center for Infection Research (DZIF) has now […]

How do antimetabolite cancer drugs damage the genetic material of malignantly transformed cells and thereby destroy them? How might these drugs be used more precisely, particularly in the treatment of pediatric tumors? A new research group led by Dr. Christopher Carnie, a scientist at the Heidelberg Faculty of Medicine at Heidelberg University, will address these […]

23 joint initiatives selected for funding – focus on long-term cooperation The strategic partnership between Heidelberg University and Harvard University is now seeing the launch of the first joint projects by researchers from the two institutions. In August 2025, their respective leading representatives had signed a Memorandum of Understanding in order to broaden the existing […]

Henrik Kaessmann receives Ernst Schering Prize for fundamental contributions to understanding mammalian evolution Prof. Dr Henrik Kaessmann has been selected to receive the 2026 Ernst Schering Prize for his pioneering research into the evolutionary origins and genetic regulation of organ development and organ function. The award, which comes with 50,000 euros in prize money, is […]

VERAXA Biotech has strengthened its financial position to support the closing of its business combination with Voyager Acquisition Corp. and support advancement of its pipeline of BiTAC-TCE and BiTAC-ADC programs toward clinical development and through initial value inflection points. ZURICH, SWITZERLAND – May 28, 2026 – VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel […]